Effects of memantine alone and with acute 'binge' cocaine on hypothalamic-pituitary-adrenal activity in the rat

European Journal of Pharmacology

Volumn 352, Issue 1, 1998, Pages 65-71

  Zhou, Yan ^a   Yuferov, Vadim P ^a   Spangler, Rudolph ^a   Maggos, Christopher E ^a   Ho, Ann ^a   Kreek, Mary Jeanne ^a  

^a ROCKEFELLER UNIVERSITY   (United States)

Author keywords

'Binge' cocaine; CRF (corticotropin releasing factor); CRF1 receptor; HPA axis; Memantine; RNase protection; Solution hybridization

Indexed keywords

COCAINE; CORTICOSTERONE; CORTICOTROPIN RELEASING FACTOR; CORTICOTROPIN RELEASING FACTOR RECEPTOR; MEMANTINE; MESSENGER RNA;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; CORTICOSTERONE RELEASE; DRUG EFFECT; HYBRIDIZATION; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; NERVE CONDUCTION; NONHUMAN; PRIORITY JOURNAL; RAT;

ADRENAL GLANDS; ADRENOCORTICOTROPIC HORMONE; ANIMALS; COCAINE; CORTICOTROPIN-RELEASING HORMONE; EXCITATORY AMINO ACID ANTAGONISTS; HYPOTHALAMUS; MALE; MEMANTINE; PITUITARY GLAND; RATS; RATS, INBRED F344; RNA, MESSENGER;

EID: 0031856240     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(98)00332-X     Document Type: Article

References (30)

1. Bormann, J., 1989. Memantine is a potent blocker of N-methyl-D-aspartate (NMDA) receptor channels. Eur. J. Pharmacol. 166, 591-592.
2. Borowsky, B., Kuhn, C.M., 1991. Monoamine mediation of cocaine-induced hypothalamo-pituitary-adrenal activation. J. Pharmacol. Exp. Ther. 256, 204-210.
3. Borowsky, B., Kuhn, C.M., 1992. D1 and D2 dopamine receptors stimulate hypothalamo-pituitary-adrenal activity in rats. Neuropharmacology 31, 671-678.
4. Branch, A.D., Unterwald, E.M., Lee, S.E., Kreek, M.J., 1992. Quantitation of preproenkephalin mRNA levels in brain regions from male Fischer rats following chronic cocaine treatment using a recently developed solution hybridization assay. Mol. Brain Res. 14, 231-238.
5. Chen, H., Pellegrini, J.W., Aggarwal, S.K., Lei, S.Z., Warach, S., Jensen, F.E., Lipton, S.A., 1992. Open channel block of N-methyl-D-aspartate (NMDA) responses by memantine: therapeutic advantage against NMDA-receptor-mediated neurotoxicity. J. Neurosci. 12, 4427-4436.
6. Contreras, P.C., Jacobson, A.E., Rice, K.C., Farah, J.M. Jr., 1991. Phencyclidine increased release of β-endorphin from anterior lobe of the pituitary. J. Pharmacol. Exp. Ther. 258, 837-841.
7. Damianopoulos, E.N., Carey, R.J., 1995. Evidence for N-methyl-D-aspartate receptor mediation of cocaine induced corticosterone release and cocaine conditioned stimulant effects. Behav. Brain Res. 68, 219-228.
8. Ditzler, K., 1991. Efficacy and tolerability of memantine in patients with dementia syndrome. Arzneim.-Forsch./Drug Res. 41, 773-780.
9. Greenamyre, J.T., Maragos, E.F., Albin, R.L., Penney, J.B., Young, A.B., 1988. Glutamate transmission and toxicity in Alzheimer's disease. Prog. Neuro-Psychopharmacol. Biol. Psychiatry 12, 421-430.
10. Hauger, R.L., Aguilera, G., 1993. Regulation of pituitary corticotropin releasing hormone (CRH) receptors by CRH: interaction with vasopressin. Endocrinology 133, 1708-1714.
11. Holmes, M.C., Antoni, F.A., Catt, K.J., Aguilera, G., 1986. Predominant release of vasopressin vs. corticotropin-releasing factor from the isolated median eminence after adrenalectomy. Neuroendocrinology 43, 245-251.
12. Imperato, A., Scrocco, M.G., Bacchi, S., Angelucci, L., 1990. NMDA receptors and in vivo dopamine release in the nucleus accumbens and caudatus. Eur. J. Pharmacol. 187, 555-556.
13. Kashihara, K., Hamamura, T., Okumura, K., Otsuki, S., 1990. Effect of MK-801 on endogenous dopamine release in vivo. Brain Res. 528, 80-82.
14. 3H]MK-801 at therapeutic concentrations in postmortem human frontal cortex. Eur. J. Pharmacol. 166, 589-590.
15. Lee, S., Rivier, C., Torres, G., 1994. Induction of c-fos and CRF mRNA by MK-801 in the parvocellular paraventricular nucleus of the rat hypothalamus. Mol. Brain Res. 24, 192-198.
16. Moldow, R.L., Fischman, A.J., 1987. Cocaine induced secretion of ACTH, Beta-endorphin, and corticosterone. Peptides 8, 819-822.
17. Pechnick, R.N., George, R., Poland, R.E., 1989. Characterization of the effects of the acute and repeated administration of MK-801 on the release of adrenocorticotropin, corticosterone and prolactin in the rat. Eur. J. Pharmacol. 164, 257-263.
18. Plotsky, P.M., 1987. Facilitation of immunoreactive corticotropin-releasing factor secretion in the hypophysial portal circulation after activation of catecholaminergic pathway or central norepinephrine injection. Endocrinology 121, 924-930.
19. Pozzoli, G., Bilezikjian, L.M., Perrin, M.H., Blount, A.L., Vale, W.W., 1996. Corticotropin-releasing factor (CRF) and glucocorticoids modulate the expression of type I CRF receptor messenger ribonucleic acid in rat anterior pituitary cell cultures. Endocrinology 137, 65-71.
20. Rivier, C., Vale, W., 1987. Cocaine stimulates adrenocorticotropin (ACTH) secretion through a corticotropin-releasing factor (CRF)-mediated mechanism. Brain Res. 422, 403-406.
21. Rivier, C., Lee, S., 1994. Stimulatory effect of cocaine on ACTH secretion: role of the hypothalamus. Mol. Cell. Neurosci. 5, 189-195.
22. Sakai, K., Horiba, N., Sakai, Y., Tozawa, F., Demura, H., Suda, T., 1996. Regulation of corticotropin-releasing factor receptor messenger ribonucleic acid in rat anterior pituitary. Endocrinology 137, 1758-1763.
23. Spanagel, R., Eilbacher, B., Wilke, R., 1994. Memantine-induced dopamine release in the prefrontal cortex and striatum of the rat - a pharmacokinetic microdialysis study. Eur. J. Pharmacol. 262, 21-26.
24. Spangler, R., Zhou, Y., Schlussman, S.D., Ho, A., Kreek, M.J., 1997. Behavioral stereotypies induced by 'binge' cocaine administration are independent of drug-induced increases in corticosterone levels. Behav. Brain Res. 86, 201-204.
25. Torres, G., Rivier, C., 1992. Cocaine-induced stimulation of the rat hypothalamic-pituitary-adrenal axis is progressively attenuated following hourly-interval regimens of the drug. Life Sci. 51, 1041-1048.
26. van de Pol, A.N., Wuarin, J., Dudek, F.E., 1990. Glutamate, the dominant excitatory transmitter in neuroendocrine regulation. Science 250, 1276-1278.
27. Weihmuller, F.B., O'Dell, S.J., Cole, B.N., Marshall, J.F., 1991. MK-801 attenuates the dopamine-releasing but not the behavioral effects of methamphetamine: an in vivo microdialysis study. Brain Res. 549, 230-235.
28. Wenk, G.L., Danysz, W., Mobley, S.L., 1994. Investigations of neurotoxicity and neuroprotection with the nucleus basalis of the rat. Brain Res. 655, 7-11.
29. Zhou, Y., Spangler, R., LaForge, K.S., Maggos, C.E., Ho, A., Kreek, M.J., 1996a. Modulation of CRF-R1 mRNA in rat anterior pituitary by dexamethasone: correlation with POMC mRNA. Peptides 17, 435-441.
30. Zhou, Y., Spangler, R., LaForge, K.S., Maggos, C.E., Ho, A., Kreek, M.J., 1996b. Corticotropin-releasing factor and CRF-R1 mRNAs in rat brain and pituitary during 'binge' pattern cocaine administration and chronic withdrawal. J. Pharmacol. Exp. Ther. 279, 351-358.